: iStockAnalyst.com Symbols Feed

Earnings Preview For Mar 16 - 20

Fri, 13 Mar 2009 21:27:00 GMT

Guess, Inc. (GES) could top expectations. FedEx Corporation (FDX) could disappoint. Adobe Systems (ADBE), Nike (NKE) and Oracle (ORCL) will also report. The earnings calendar is limited this week with just 93 companies confirmed to report. First-quarter earnings season will[More...]

Orchid Cellmark Looks to Blossom - Analyst Blog

Mon, 03 Nov 2008 18:27:00 GMT

Orchid Cellmark Inc. (ORCH) is a leading provider of DNA testing services for forensic, human identity and agricultural applications in the U.S. and the U.K. The company is also the world's largest provider of scrapie susceptibility genotyping. Orchid Cellmark is now leveraging its expertise in DNA testing to enter into new markets like pork traceability, immigration testing and security applications. Recent market conditions have left the stock trading close to the 52-week low. We expect the company to benefit from the accretive effect of the ReliaGene acquisition in the second half of 2008. Additionally, revenue from the mega tender in the U.K. will positively impact the company's topline in 2009. As such, we maintain our Buy rating on the stock with a revised target price of $5.00. We[More...]

Analyst Comments: SMI, Gushan, Priceline, ArthroCare, ZOLL Medical, Orchid Cellmark, Charlotte Russe, Hoku Scientific, 3SBio, Skechers, Coca-Cola Hellenic

Tue, 07 Oct 2008 18:17:00 GMT

Semiconductor Manufacturing International (SMI) is a Chinese semiconductor foundry company with multiple integrated chip wafer fabrication plants. SMI is the largest foundry company in China (third largest worldwide) and operates multiple plants and fabrication (fab) lines. Strategic alliances with Chartered, Toshiba, Infineon (IFX), Fujitsu, Motorola (MOT), Elpida and IMEC have provided access to intellectual property (IP) associated with a variety of semiconductor process technologies. We remain concerned regarding operational performance in the near-term given severe price declines in DRAM. The firm has announced they plan to exit the DRAM business. We[More...]

Sweet Smell of Orchid Cellmark

Mon, 12 May 2008 20:36:16 GMT

Orchid Cellmark, Inc. (ORCH) is a leading provider of DNA testing services for forensic, human identity and agricultural applications in the U.S. and the U.K. The company is also the world's largest provider of scrapie susceptibility genotyping.[More...]

Orchid Cellmark: DNA-Based Tests Confirm: Best Small Cap Idea! - BofA

Mon, 03 Dec 2007 14:38:20 GMT

- Banc of America is very positive on Orchid Cellmark (NASDAQ:ORCH) calling it their Best Small Cap Idea after ORCH management agreed to participate in two days of investor meetings. This comes on the heels of the sell-off in the stock after the company reported in line EPS on lower revenues, the esults reflected a drop off in scrapie testing volumes, but the weaker stock price was unwarranted in BAC's view, given signs of a pick up in its forensics business in the latest period, as well as ongoing profit improvement and positive cash flow generation....[More...]

Orchid Cellmark Reports Second Quarter 2009 Financial Results

Thu, 30 Jul 2009 10:57:00 GMT

Orchid Cellmark Inc. , a leading international provider of identity DNA testing services, today reported its financial results for the second quarter of 2009.[More...]

Orchid Cellmark to Announce Second Quarter 2009 Financial Results On July 30, 2009

Thu, 23 Jul 2009 10:56:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, will release its second quarter 2009 financial results on Thursday, July 30, 2009 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the 2009 second quarter as well as operating highlights. A question-and-answer session will follow management's discussion.[More...]

Orchid Cellmark Reports Improved First Quarter 2009 Financial Results

Thu, 07 May 2009 11:52:00 GMT

PRINCETON, N.J. May 7 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, today reported its financial results for the first quarter of 2009.
Total revenues were $14.0 million for the first quarter of 2009 compared to $14.5 million for the first quarter of 2008, despite the adverse impact of foreign exchange rates which reduced U.K. revenues by 27%.
In dollars, total U.K.-based revenues for the first quarter of 2009 increased by approximately 1% over the first quarter of 2008.

[More...]

Orchid Cellmark to Present at the 2009 Bank of America Health Care Conference on May 13th

Wed, 29 Apr 2009 20:04:00 GMT

Orchid Cellmark Inc., , today announced that Thomas A. Bologna, President and Chief Executive Officer of Orchid Cellmark, is scheduled to present at the 2009 Bank of America Health Care Conference in New York City on Wednesday, May 13, 2008 at 4:00 p.m. EDT[More...]

Orchid Cellmark to Announce First Quarter 2009 Financial Results on May 7, 2009

Mon, 27 Apr 2009 14:23:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, will release its first quarter 2009 financial results on Thursday, May 7, 2009 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the 2009 first quarter as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.[More...]

Zacks Analyst Blog Highlights: AK Steel Holding Corp, Guess? Inc, AIG, Sony Corp and Orchid Cellmark Inc.

Mon, 23 Mar 2009 11:40:00 GMT

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Stocks recently featured in the blog include: AK Steel Holding Corp (NYSE: AKS), Guess?
Inc (NYSE: GES), AIG (NYSE: AIG), Sony Corp (NYSE: SNE) and Orchid Cellmark Inc (NASDAQ: ORCH).

[More...]

Orchid Cellmark Reports Fourth Quarter and Full Year 2008 Financial Results

Mon, 16 Mar 2009 10:56:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2008.[More...]

Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on March 16, 2009

Fri, 06 Mar 2009 12:56:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, will release its fourth quarter and year-end 2008 financial results on Monday, March 16, 2009 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the 2008 fourth quarter and year-end results as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.[More...]

Orchid Cellmark Reports Third Quarter 2008 Financial Results

Thu, 30 Oct 2008 10:56:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, today reported its financial results for the third quarter of 2008.[More...]

Orchid Cellmark to Announce Third Quarter 2008 Financial Results on October 30, 2008

Fri, 24 Oct 2008 10:56:00 GMT

Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, will release its third quarter 2008 financial results on Thursday, October 30, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the third quarter 2008 as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.[More...]